Faculty of medicine, Cairo University
Cairo, Al-Manial, Cairo, Egypt, Egypt, 11451, Egypt
NCT Number: NCT07777146
This prospective randomized controlled trial will include adult patients with ODS, anterior rectocele ≥3 cm, and excessive perineal descent following failure of conservative treatment.
Patients will be randomized 1:1 to STARR alone or STARR combined with transverse perineal support procedure using polypropylene mesh. The primary outcome will be Change in Altomare Obstructed Defecation Syndrome (ODS) score in both groups. Secondary outcomes will include operative time, postoperative pain, surgical complications, surgical site infection, and sexual function assessed using the PISQ-12. Patients will be followed up twice during the first postoperative week, weekly during the first month, and monthly thereafter.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Cairo, Al-Manial, Cairo, Egypt, Egypt, 11451, Egypt
This will be a prospective, randomized controlled trial conducted at Kasr Al-Ainy Hospitals, Cairo University, including adult patients of either sex with obstructed defecation syndrome (ODS) associated with rectocele, and excessive perineal descent. Eligible patients must have anterior rectocele ≥3 cm, excessive perineal descent, and failure of conservative treatment. Patients with Slow-transit constipation, anterior rectocele of < 3 cm, complete external rectal prolapse, evidence of colorectal carcinoma or Inflammatory bowel disease ( IBD), Patients with fecal incontinence, Inability for lifestyle change postoperatively, or previous surgeries for anterior rectocele will be excluded.
Following informed written consent, Eligible participants will be randomized in a 1:1 ratio using computer-generated randomization, with allocation concealment through sequentially numbered, opaque, sealed envelopes.
Patients will be allocated to either Group A (STARR alone) or Group B (STARR combined with transverse perineal support using non-absorbable polypropylene mesh). Postoperative assessment will include operative time, pain using the visual analogue scale, and postoperative complications.
Patients will be followed-up twice weekly in the first postoperative week, weekly during the first month, and monthly thereafter. The primary outcome will be Change in Altomare Obstructed Defecation Syndrome (ODS) score in both groups. Secondary outcomes will include operative time, postoperative pain, surgical site infection, sexual function assessed by Pelvic Organ Prolapse/Urinary incontinence sexual questionnaire (PISQ-12), and postoperative complications.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The STARR procedure will be performed using PPH circular stapler to achieve trans-anal full-thickness resection of the rectocele
Transverse perineal support procedure will be added to STARR procedure. it will be done using a non-absorbable polypropylene mesh to reinforce the perineal body and correct excessive perineal descent.
Time frame: Up to 6 months postoperatively
Compare Change in Altomare Obstructed Defecation Syndrome (ODS) score in both groups. Altomare Obstructed Defecation Syndrome (ODS) score ranges from 0 to 31. Higher scores indicate a worse outcome (more severe obstructed defecation symptoms )
Time frame: During surgery
Compare time of operation between both procedure
Time frame: Up to 6 months postoperatively
compare surgical site infection in both groups (surgical site infection: infection at or near a surgical incision within 30 days post-surgery, marked by redness, swelling, or pus.)
Time frame: Within 48 hours postoperatively
Compare incidence of postoperative urine retention in both groups. (Postoperative urinary retention: inability to void spontaneously after surgery with a bladder volume ≥500 mL on bladder ultrasound).
Time frame: Up to 6 months postoperatively
Compare Pain intensity measured using Visual Analogue Scale between both groups (Visual Analogue Scale for Pain: ranges from 0 to 10 . Higher scores indicate a worse outcome {greater pain intensity})
Time frame: Up to 6 months postoperatively
Compare sexual function in both groups using Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ- 12). PISQ-12 score ranges from 0 to 48. Higher scores indicate better sexual function
Time frame: From date of hospital admission until date of hospital discharge, assessed up to 10 days after surgery
Compare how many days patients stay in hospital in both groups
Contact information is provided by the study sponsor or research team.
Cairo University
Other
Effect of Adding Transverse Perineal Support to Stapled Transanal Rectal Resection for Anterior Rectocele With Excessive Perineal Descent: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06604702
Digestive System Diseases, Gastrointestinal Diseases
View Trial DetailsNCT02052063
Digestive System Diseases, Gastrointestinal Diseases
Rouen, France
View Trial DetailsNCT06252714
Bowel Dysfunction, Digestive System Diseases
Cincinnati, Ohio, United States
View Trial DetailsNCT06430931
Colorectal Disorders, Cystocele
Amersfoort, Utrecht, Netherlands
View Trial Details